Morgan Stanley has a consensus price target of $85.86, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, HSBC, and JMP Securities on April 30, 2024, April 19, 2024, and April 19, 2024. With an average price target of $69 between Oppenheimer, HSBC, and JMP Securities, there's an implied -30.71% downside for Morgan Stanley from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/30/2024 | Buy Now | 5.44% | Oppenheimer | Chris Kotowski | $101 → $105 | Maintains | Outperform | Get Alert |
04/19/2024 | Buy Now | 2.43% | HSBC | Saul Martinez | $100 → $102 | Maintains | Hold | Get Alert |
04/19/2024 | Buy Now | — | JMP Securities | Devin Ryan | — | Reiterates | → Market Perform | Get Alert |
04/18/2024 | Buy Now | — | JMP Securities | Devin Ryan | — | Reiterates | → Market Perform | Get Alert |
04/18/2024 | Buy Now | 18.5% | BMO Capital | James Fotheringham | $115 → $118 | Maintains | Outperform | Get Alert |
04/17/2024 | Buy Now | 9.46% | Jefferies | Daniel Fannon | $107 → $109 | Maintains | Buy | Get Alert |
04/17/2024 | Buy Now | 6.45% | B of A Securities | Michael Carrier | $100 → $106 | Maintains | Buy | Get Alert |
04/17/2024 | Buy Now | -1.59% | Keefe, Bruyette & Woods | David Konrad | $94 → $98 | Maintains | Market Perform | Get Alert |
04/17/2024 | Buy Now | 1.43% | Oppenheimer | Chris Kotowski | $97 → $101 | Maintains | Outperform | Get Alert |
04/16/2024 | Buy Now | 8.46% | CFRA | Kenneth Leon | $97 → $108 | Maintains | Buy | Get Alert |
04/09/2024 | Buy Now | — | JMP Securities | Devin Ryan | — | Reiterates | → Market Perform | Get Alert |
04/05/2024 | Buy Now | -5.6% | Keefe, Bruyette & Woods | David Konrad | $91 → $94 | Maintains | Market Perform | Get Alert |
04/04/2024 | Buy Now | 2.43% | Evercore ISI Group | Glenn Schorr | $97 → $102 | Maintains | Outperform | Get Alert |
03/28/2024 | Buy Now | 0.42% | HSBC | Saul Martinez | $96 → $100 | Maintains | Hold | Get Alert |
03/27/2024 | Buy Now | -8.62% | RBC Capital | Gerard Cassidy | → $91 | Reiterates | Sector Perform → Sector Perform | Get Alert |
03/19/2024 | Buy Now | -2.59% | Oppenheimer | Chris Kotowski | $109 → $97 | Maintains | Outperform | Get Alert |
01/30/2024 | Buy Now | 9.46% | Oppenheimer | Chris Kotowski | $106 → $109 | Maintains | Outperform | Get Alert |
01/17/2024 | Buy Now | 6.45% | Oppenheimer | Chris Kotowski | $107 → $106 | Maintains | Outperform | Get Alert |
01/17/2024 | Buy Now | 7.45% | BMO Capital | James Fotheringham | $106 → $107 | Maintains | Outperform | Get Alert |
01/17/2024 | Buy Now | -8.62% | Keefe, Bruyette & Woods | David Konrad | $102 → $91 | Downgrade | Outperform → Market Perform | Get Alert |
01/17/2024 | Buy Now | -12.63% | JP Morgan | Kian Abouhossein | $94 → $87 | Downgrade | Overweight → Neutral | Get Alert |
01/09/2024 | Buy Now | -4.6% | UBS | Brennan Hawken | $80 → $95 | Maintains | Neutral | Get Alert |
01/09/2024 | Buy Now | -5.6% | JP Morgan | Kian Abouhossein | $92 → $94 | Maintains | Overweight | Get Alert |
01/09/2024 | Buy Now | -3.6% | HSBC | Saul Martinez | → $96 | Downgrade | Buy → Hold | Get Alert |
01/04/2024 | Buy Now | 0.42% | B of A Securities | Michael Carrier | $95 → $100 | Maintains | Buy | Get Alert |
01/02/2024 | Buy Now | 16.49% | Barclays | Jason Goldberg | $102 → $116 | Maintains | Overweight | Get Alert |
12/21/2023 | Buy Now | -14.64% | RBC Capital | Gerard Cassidy | → $85 | Reiterates | Sector Perform → Sector Perform | Get Alert |
12/19/2023 | Buy Now | 0.42% | Goldman Sachs | Richard Ramsden | $89 → $100 | Maintains | Buy | Get Alert |
11/28/2023 | Buy Now | -19.66% | Societe Generale | Andrew Lim | → $80 | Downgrade | Buy → Hold | Get Alert |
11/20/2023 | Buy Now | -14.64% | Exane BNP Paribas | Jeremy Sigee | → $85 | Downgrade | Outperform → Neutral | Get Alert |
The latest price target for Morgan Stanley (NYSE: MS) was reported by Oppenheimer on April 30, 2024. The analyst firm set a price target for $105.00 expecting MS to rise to within 12 months (a possible 5.44% upside). 49 analyst firms have reported ratings in the last year.
The latest analyst rating for Morgan Stanley (NYSE: MS) was provided by Oppenheimer, and Morgan Stanley maintained their outperform rating.
The last upgrade for Morgan Stanley happened on October 20, 2023 when Wolfe Research raised their price target to N/A. Wolfe Research previously had an underperform for Morgan Stanley.
The last downgrade for Morgan Stanley happened on January 17, 2024 when Keefe, Bruyette & Woods changed their price target from $102 to $91 for Morgan Stanley.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Morgan Stanley, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Morgan Stanley was filed on April 30, 2024 so you should expect the next rating to be made available sometime around April 30, 2025.
While ratings are subjective and will change, the latest Morgan Stanley (MS) rating was a maintained with a price target of $101.00 to $105.00. The current price Morgan Stanley (MS) is trading at is $99.58, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.